May 2008
Volume 49, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2008
Production of Anti-CEP Autoantibodies in Immune Mediated Retinal Degeneration
Author Affiliations & Notes
  • V. L. Perez
    Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida
  • M. West
    Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida
  • M. E. Raybourn
    Ophthalmic Research, Cleveland Clinic Foundation, Cleveland, Ohio
  • X. Yang
    Ophthalmic Research, Cleveland Clinic Foundation, Cleveland, Ohio
  • K. G. Shadrach
    Ophthalmic Research, Cleveland Clinic Foundation, Cleveland, Ohio
  • J. G. Hollyfield
    Ophthalmic Research, Cleveland Clinic Foundation, Cleveland, Ohio
  • Footnotes
    Commercial Relationships  V.L. Perez, Cleveland Clinic Foundation, P; M. West, None; M.E. Raybourn, None; X. Yang, Cleveland Clinic Foundation, P; K.G. Shadrach, None; J.G. Hollyfield, Cleveland Clinic Foundation, P.
  • Footnotes
    Support  NIH Grant KO8 EY014912-05 (VLP); P30EY014801 (BPEI); Research to Prevent Blindness (BPEI and CCF)
Investigative Ophthalmology & Visual Science May 2008, Vol.49, 202. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      V. L. Perez, M. West, M. E. Raybourn, X. Yang, K. G. Shadrach, J. G. Hollyfield; Production of Anti-CEP Autoantibodies in Immune Mediated Retinal Degeneration. Invest. Ophthalmol. Vis. Sci. 2008;49(13):202. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : We have previously reported a novel murine model of immune mediated retinal degeneration induced by immunization with carboxyethylpyrrole (CEP)-modified albumin (CEP-MSA). CEP albumin adducts are generated in the retinal photoreceptors in response to oxidative stress and patients with age-related macular degeneration (AMD) have circulating CEP autoantibodies. The goal of this work is to test the role of anti-CEP antibody production in the generation of immune mediated retinal degeneration.

Methods: : C57BL/6 were immunized in the footpad with CEP-MSA or non-adducted MSA emulsified in complete Freund’s adjuvant (CFA) followed with a subcutaneous challenge at day 10 with incomplete Freund’s adjuvant-CEP-MSA in the skin of the neck, followed by a second subcutaneous challenge two months later with CFA-MSA. Serum was collected at different time points and anti-CEP production was analyzed by ELISA. Specificity of anti-CEP autoantibody to retinal tissue was assessed by performing western blot analysis on retinal extracts and immunohistochemical staining using sera from immunized mice. Anti-CEP sera from immunized groups were also tested on human eye tissue from AMD and control individuals.

Results: : Anti-CEP-MSA autoantibody could be detected in immunized mice by day 30 after immunization and persisted for 12 months. A single band of approximately 40 kD was detected by western blot analysis of retinal extracts probed with sera form immunized mice. Immunohistochemical analysis demonstrates that the anti-CEP sera antibodies localized to scattered areas of the retinal pigment epithelium and photoreceptors. Moreover, anti-CEP serum binds to areas of drusen formation in the retina of human patients with AMD

Conclusions: : Oxidative stress immune mediated retinal degeneration correlates with the production of autoantibodies against CEP modified protein. These antibodies recognize specific areas of the retina where the antigen is present and have the potential of mediating disease.

Keywords: autoimmune disease • immunomodulation/immunoregulation • oxidation/oxidative or free radical damage 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×